ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 252

$652K Total Retail Price of All Prescriptions

Rank: 61 out of 252

757 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 757 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 757 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,093 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 578 503 1 2
LISINOPRIL 461 387 2 3
AMLODIPINE BESYLATE 421 352 3 4
LEVOTHYROXINE SODIUM 359 271 4 1
OMEPRAZOLE 332 267 5 6
HYDROCODONE-ACETAMINOPHEN 291 139 S3 6 5
ZOLPIDEM TARTRATE 256 176 7 21
MELOXICAM 205 160 8 20
METFORMIN HCL 199 163 9 9
CITALOPRAM HBR 190 104 10 15
METOPROLOL TARTRATE 185 138 11 10
FLUTICASONE PROPIONATE 137 98 12 36
PRAVASTATIN SODIUM 137 117 12 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 108 14 25
ALENDRONATE SODIUM 131 131 15 32
LOVASTATIN 128 102 16 39
FUROSEMIDE 126 106 17 7
TRIAMTERENE-HCTZ 123 111 18 33
HYDROCHLOROTHIAZIDE 122 109 19 13
ATENOLOL 113 88 20 18
NEXIUM 111 71 21 23
TRAMADOL HCL 111 92 21 17
ATORVASTATIN CALCIUM 110 88 23 16
POTASSIUM CHLORIDE 109 82 24 8
GLIPIZIDE 96 90 25 52
AMLODIPINE BESYLATE-BENAZEPRIL 96 81 25 60
WARFARIN SODIUM 91 80 27 14
VERAPAMIL ER 90 82 28 83
GABAPENTIN 88 58 29 11
TRAZODONE HCL 88 76 29 31
DIGOXIN 86 68 31 44
TRIAMTERENE-HYDROCHLOROTHIAZID 83 77 32 134
GEMFIBROZIL 80 66 33 98
METOPROLOL SUCCINATE 79 79 34 19
GLYBURIDE 74 51 R 35 78
DOXAZOSIN MESYLATE 73 65 36 73
ALLOPURINOL 73 70 36 30
LANTUS 67 58 38 55
GLYBURIDE-METFORMIN HCL 64 50 R 39 82
TAMSULOSIN HCL 63 61 40 26
AMITRIPTYLINE HCL 61 44 R 41 46
FENOFIBRATE 58 42 42 64
FLUOXETINE HCL 57 33 43 57
SYNTHROID 56 52 44 47
QUETIAPINE FUMARATE 56 48 44 77
CLOPIDOGREL 54 46 46 29
ISOSORBIDE MONONITRATE ER 53 40 47 50
SERTRALINE HCL 53 48 47 27
LOSARTAN POTASSIUM 52 52 49 24
GLIMEPIRIDE 52 40 49 40
QUINAPRIL HCL 50 34 51 120
CRESTOR 50 37 51 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.